Abstract
The application of quality control and assurance procedures to the components of animal cell cultures has transformed what was an art to a viable industrial technology. This results in the successful large scale operation of such cultures. However it is clear that the cost of obtaining a license to produce materials from animal cells in culture severely impedes the movement of products into the market place. It is therefore necessary to examine in more detail the reasons for the reluctance of the regulatory authorities to issue product licences and in particular to appreciate the way ethical issues influence this process. This paper reviews these issues and indicates a way ahead.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Birch JR, Bonnerjea J, Flatman S and Vranch S (1996a) The Production of Monoclonal Antibodies, In: Birch JR and Lennox ES (eds) Monoclonal Antibodies, Principles and Applications, Pub Wiley-Liss, New York, 232.
Birch JR, Bonnerjea J, Flatman S and Vranch S (1996b) The Production of Monoclonal Antibodies, In: Birch JR and Lennox ES (eds) Monoclonal Antibodies, Pinciples and Applications, Pub Wiley-Liss, New York, 235–236.
Cherry RS and Papoutsakis E (1990) In: Spier RE and Griffiths JB (eds) Animal Cell Biotechnology vol 4, Academic Press, London 72–122. Understanding and controlling fluid-mechanical injury of animal cells in bioreactors.
Guderman F, Lutkemeyer D and Lehmann J (1994) Cytotechnology vol 15 301–309. Design of a bubble-swarm bioreactor for animal cell culture.
Handa-Corrigan A (1990) In: Spier RE and Griffiths JB (eds) Animal Cell Biotechnology vol 4, Academic Press, London 123–132. Oxygenating animal cell cultures: the remaining problems.
Kessler DA and Feiden KL (1995) Scientific American vol 272, 26–32. Faster Evaluation of Vital Drugs.
McCullough K and Spier RE (1990) Monoclonal Antibodies in biotechnology: theoretical and practical aspects. Cambridge University Press, Cambridge, 282–284.
Spier RE and Whiteside JP (1983) Dev. Biol. Standard., v 55, pp 151–152. The description of a device which facilitates the oxygenation of microcarrier cultures.
Spier RE and Whiteside JPW (1990) In: Spier RE and Griffiths JB (eds). Animal Cell Biotechnology vol 4, Academic Press, London 133–148. The oxygenation of animal cell cultures by bubbles.
Spier RE (1996a) Bioreactor Design for Animal Cell Cultures: With Special Reference to Mass Transfer, In: Moreita AR and Wallace KK (eds). Computer and Information Science Applications in Bioprocess Engineering, Pub Kluwer Acad. the Netherlands, 325–347.
Spier RE (1996b) Science and Engineering Ethics on the Acceptability of Biopharmaceuticals, vol 2, 291–306.
Thomas CR, Al-Rubei M and Zhang Z (1994) Cytotechnology vol 15, 29–335. Prediction of mechanical damage to animal cells in turbulence.
Vagelos PR (1991) Science vol 252, 1080–1084. Are prescription drug proces too high.
Wolfe T (1979) “The righ stuff” Black Swan Books, London.
Zhang S, Handa-Corrigan A and Soier RE (1992) Biotech Bioeng, v 40, pp 252–259. Oxygen transfer propeties of bubbles in animal cell culture media.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Spier, R.E. Factors limiting the commercial application of animal cells in culture. Cytotechnology 23, 113–117 (1997). https://doi.org/10.1023/A:1007975904301
Issue Date:
DOI: https://doi.org/10.1023/A:1007975904301